Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii

Int J Antimicrob Agents. 2008 Sep;32(3):281-4. doi: 10.1016/j.ijantimicag.2008.04.013. Epub 2008 Jul 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acinetobacter Infections / drug therapy*
  • Acinetobacter Infections / microbiology
  • Acinetobacter baumannii / drug effects*
  • Adult
  • Aged
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Carbapenems / pharmacology*
  • Colistin / adverse effects
  • Colistin / pharmacology
  • Colistin / therapeutic use*
  • Drug Resistance, Bacterial
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Pneumonia, Ventilator-Associated / drug therapy*
  • Pneumonia, Ventilator-Associated / microbiology
  • Rifampin / adverse effects
  • Rifampin / pharmacology
  • Rifampin / therapeutic use*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Carbapenems
  • Rifampin
  • Colistin